Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online January 11, 2007
Stem Cells Vol. 25 No. 4 April 2007, pp. 950 -960
doi:10.1634/stemcells.2006-0326; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0326v1
25/4/950    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toh, W. S.
Right arrow Articles by Cao, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toh, W. S.
Right arrow Articles by Cao, T.

EMBRYONIC STEM CELLS

Effects of Culture Conditions and Bone Morphogenetic Protein 2 on Extent of Chondrogenesis from Human Embryonic Stem Cells

Wei Seong Toha, Zheng Yanga,b, Hua Liua, Boon Chin Henga, Eng Hin Leeb, Tong Caoa

aStem Cell Laboratory, Faculty of Dentistry, and
bDepartment of Orthopaedic Surgery, Yong Loo Lin School of Medicine, Tissue Engineering Program, National University of Singapore, Singapore

Key Words. Bone morphogenetic protein 2 • Chondrogenic • Differentiation • Embryonic stem cells • Human

Correspondence: Tong Cao, D.D.S., Ph.D., Stem Cell Laboratory, Faculty of Dentistry, National University of Singapore, 5 Lower Kent Ridge Road, Singapore 119-074. Telephone: +65 651-64630; Fax: +65 677-45701; e-mail: omscaot{at}nus.edu.sg

Received May 30, 2006; accepted for publication December 27, 2006.
First published online in STEM CELLS EXPRESS   January 11, 2007.



The study of human embryonic stem cells (hESCs) can provide invaluable insights into the development of numerous human cell and tissue types in vitro. In this study, we addressed the potential of hESCs to undergo chondrogenesis and demonstrated the potential of hESC-derived embryoid bodies (EBs) to undergo a well-defined full-span chondrogenesis from chondrogenic induction to hypertrophic maturation. We compared chondrogenic differentiation of hESCs through EB direct-plating outgrowth system and EB-derived high-density micromass systems under defined serumfree chondrogenic conditions and demonstrated that cell-tocell contact and bone morphogenetic protein 2 (BMP2) treatment enhanced chondrocyte differentiation, resulting in the formation of cartilaginous matrix rich in collagens and proteoglycans. Provision of a high-density three-dimensional (3D) microenvironment at the beginning of differentiation is critical in driving chondrogenesis because increasing EB seeding numbers in the EB-outgrowth system was unable to enhance chondrogenesis. Temporal order of chondrogenic differentiation and hypertrophic maturation indicated by the gene expression profiles of Col 1, Col 2, and Col 10, and the deposition of extracellular matrix (ECM) proteins, proteoglycans, and collagen II and X demonstrated that the in vivo progression of chondrocyte maturation is recapitulated in the hESC-derived EB model system established in this study. Furthermore, we also showed that BMP2 can influence EB differentiation to multiple cell fates, including that of extraembryonic endodermal and mesenchymal lineages in the EB-outgrowth system, but was more committed to driving the chondrogenic cell fate in the EB micromass system. Overall, our findings provide a potential 3D model system using hESCs to delineate gene function in lineage commitment and restriction of chondrogenesis during embryonic cartilage development.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Stem CellsHome page
D. A. Rider, C. Dombrowski, A. A. Sawyer, G. H. B. Ng, D. Leong, D. W. Hutmacher, V. Nurcombe, and S. M. Cool
Autocrine Fibroblast Growth Factor 2 Increases the Multipotentiality of Human Adipose-Derived Mesenchymal Stem Cells
Stem Cells, June 1, 2008; 26(6): 1598 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Jukes, S. K. Both, A. Leusink, L. M. Th. Sterk, C. A. van Blitterswijk, and J. de Boer
Endochondral bone tissue engineering using embryonic stem cells
PNAS, May 13, 2008; 105(19): 6840 - 6845.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. M. Hoben, E. J. Koay, and K. A. Athanasiou
Fibrochondrogenesis in Two Embryonic Stem Cell Lines: Effects of Differentiation Timelines
Stem Cells, February 1, 2008; 26(2): 422 - 430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2007 by AlphaMed Press.